Up‐regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide. Issue 2 (28th November 2019)
- Record Type:
- Journal Article
- Title:
- Up‐regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide. Issue 2 (28th November 2019)
- Main Title:
- Up‐regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide
- Authors:
- Palomo, Marta
Vera, Manel
Martin, Susana
Torramadé‐Moix, Sergi
Martinez‐Sanchez, Julia
Belen Moreno, Ana
Carreras, Enric
Escolar, Ginés
Cases, Aleix
Díaz‐Ricart, Maribel - Abstract:
- Abstract: Endothelial dysfunction is an earlier contributor to the development of atherosclerosis in chronic kidney disease (CKD), in which the role of epigenetic triggers cannot be ruled out. Endothelial protective strategies, such as defibrotide (DF), may be useful in this scenario. We evaluated changes induced by CKD on endothelial cell proteome and explored the effect of DF and the mechanisms involved. Human umbilical cord vein endothelial cells were exposed to sera from healthy donors (n = 20) and patients with end‐stage renal disease on haemodialysis (n = 20). Differential protein expression was investigated by using a proteomic approach, Western blot and immunofluorescence. HDAC1 and HDAC2 overexpression was detected. Increased HDAC1 expression occurred at both cytoplasm and nucleus. These effects were dose‐dependently inhibited by DF. Both the HDACs inhibitor trichostatin A and DF prevented the up‐regulation of the endothelial dysfunction markers induced by the uraemic milieu: intercellular adhesion molecule‐1, surface Toll‐like receptor‐4, von Willebrand Factor and reactive oxygen species. Moreover, DF down‐regulated HDACs expression through the PI3/AKT signalling pathway. HDACs appear as key modulators of the CKD‐induced endothelial dysfunction as specific blockade by trichostatin A or by DF prevents endothelial dysfunction responses to the CKD insult. Moreover, DF exerts its endothelial protective effect by inhibiting HDAC up‐regulation likely through PI3K/AKT.
- Is Part Of:
- Journal of cellular and molecular medicine. Volume 24:Issue 2(2020)
- Journal:
- Journal of cellular and molecular medicine
- Issue:
- Volume 24:Issue 2(2020)
- Issue Display:
- Volume 24, Issue 2 (2020)
- Year:
- 2020
- Volume:
- 24
- Issue:
- 2
- Issue Sort Value:
- 2020-0024-0002-0000
- Page Start:
- 1713
- Page End:
- 1723
- Publication Date:
- 2019-11-28
- Subjects:
- chronic kidney disease -- defibrotide -- endothelial dysfunction -- HDAC -- HDAC1 -- HDAC2 -- inflammation -- oxidative stress
Cytology
Medicine
Molecular Biology
Cytologie -- Périodiques
Médecine -- Périodiques
Biologie moléculaire -- Périodiques
Cytology -- Periodicals
Medicine -- Periodicals
Molecular biology -- Periodicals
611.01805 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1582-4934 ↗
http://www.blackwell-synergy.com/loi/jcmm ↗
http://www.usc.edu/hsc/nml/e-resources/info/joucelmm.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jcmm.14865 ↗
- Languages:
- English
- ISSNs:
- 1582-1838
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.005000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21622.xml